Perhaps the efficacy constraint lies with the rather soft observed motor behaviour measure rather than a more biological difference as with most drug response studies. That the Rett organisation, parents and therapists give such strong support to the study after participating in endless previous trials, might indicate that something else is at play for which there is no other appropriate objective measure. A CNS biologic would be great but one hopes that this study might help better define learning capabilities or task performance for which psychologists have accepted programmes. While few sellers are leaving, it is somewhat disturbing that equally few are sufficiently motivated to come aboard until more positive results come to hand. The risk profile reduces with each advance so we don't have long to wait.
NEU Price at posting:
5.5¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)